Severely ill COVID-19 patients have altered circulating levels of proteins controlling the epitranscriptome - 17/05/23
Doi : 10.1016/j.jinf.2023.03.002
A. Quiles-Jiménez ⁎ 
Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
⁎Corresponding author at: Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.Research Institute of Internal Medicine, Oslo University HospitalOsloNorway
M.M.L. Sousa
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
PROMEC Core Facility for Proteomics and Metabolomics, NTNU and the Central Norway Regional Health Authority, Trondheim, Norway
C. Huse
Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
A.M. Dyrhol-Riise
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway
J.C. Holter
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Department of Microbiology, Oslo University Hospital, Oslo, Norway
E.E. Christensen
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway
K. Tonby
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway
A.R. Holten
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Department of Acute Medicine, Oslo University Hospital, Oslo, Norway
P. Aukrust
Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway
M. Bjørås
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
Department of Microbiology, Oslo University Hospital, Oslo, Norway
B. Halvorsen
Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
Plan
| ☆ | T.B. Dahl and B. Halvorsen shared authorship. |
© 2023
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 86 - N° 6
P. 593-595 - juin 2023 Retour au numéro
Article précédent
- Emergence of epidemic variants of SARS-CoV-2 by acquiring combinations of new highly mutable nucleotides in its genome
- Hui Wang, Yuqi Liu, Peng Li, Chaowu Liu, Kuibiao Li, Lan Cao, Ying Zhang, Zichun Cheng, Kailing Huang, Zhouxia Zheng, Xiaoqian Xin, Yifeng Liu, Xiaofang Peng, Dan Liang, Bixia Ke, Tao Wang, Qingpei Chen, Weihua Luo, Chaolang Qin, Lihong Sun, Guobing Chen, Oscar Junhong Luo, Jixi Li, Qiao Zhang, Biao Di, Zhoubin Zhang, Changwen Ke, Hongling Jia, Feng Gao
- Genetic and structural genome-based survey reveals the low potential for epidemiological expansion of the SARS-CoV-2 XBB.1.5 sublineage
- Fabio Scarpa, Elena Imperia, Ilenia Azzena, Marta Giovanetti, Domenico Benvenuto, Chiara Locci, Marco Casu, Pier Luigi Fiori, Antonello Maruotti, Giancarlo Ceccarelli, Alessandra Borsetti, Arnaldo Caruso, Roberto Cauda, Antonio Cassone, Allegra Via, Stefano Pascarella, Daria Sanna, Massimo Ciccozzi
Bienvenue sur EM-consulte, la référence des professionnels de santé.